scholarly journals Sex, Oxidative Stress, and Hypertension: Insights From Animal Models

Physiology ◽  
2019 ◽  
Vol 34 (3) ◽  
pp. 178-188 ◽  
Author(s):  
Jane F. Reckelhoff ◽  
Damian G. Romero ◽  
Licy L. Yanes Cardozo

One of the mechanisms responsible for blood pressure (BP) regulation is thought to be oxidative stress. In this review, we highlight preclinical studies that strongly support a role for oxidative stress in development and maintenance of hypertension in male animals, based on depressor responses to antioxidants, particularly tempol and apocynin. In females, oxidative stress seems to be important in the initial development of hypertension. However, whether maintenance of hypertension in females is mediated by oxidative stress is not clear. In clinical studies, pharmacological intervention to reduce BP with antioxidants has conflicting results, mostly negative. This review will discuss the uncertainties regarding blood pressure control and oxidative stress and potential reasons for these outcomes.

2007 ◽  
Vol 34 (9) ◽  
pp. 938-945 ◽  
Author(s):  
Julio C Sartori-Valinotti ◽  
Radu Iliescu ◽  
Lourdes A Fortepiani ◽  
Licy L Yanes ◽  
Jane F Reckelhoff

Hypertension ◽  
2015 ◽  
Vol 66 (suppl_1) ◽  
Author(s):  
Mariela Mendez

Leptin is enhanced in animal models of obesity. The role of leptin in hypertension is unclear with some studies showing antihypertensive actions and others showing a pro-hypertensive role. In normotensive, non-obese, animals, infusion of leptin induces natriuresis. However, in animal models of enhanced oxidative stress, obesity, or activated renin-angiotensin system, infusion of leptin tends to increase blood pressure. Renin is a critical mediator of angiotensin-II formation, and thus blood pressure control. However, the direct effect of leptin on the release of renin from juxtaglomerular (JG) cells has not been studied. We hypothesize that under normal conditions leptin does not affect renin release whereas during high oxidative stress leptin stimulates renin release. We isolated primary cultures of mouse juxtaglomerular (JG) cells. After treatment with different agonists, renin released to the supernatant was measured by radioimmunoassay. We first tested the direct effect of murine leptin on renin release. We found that 1 hr treatment with leptin (0.1-1 uM) decreased basal renin by 20 ± 5% (p<0.05; n=8). Treatment of JG cells for longer periods (4 and 24 hrs) did not affect renin release (n=6) or total renin expression (n=4). We then tested whether oxidative stress modified the effect of leptin on renin release. For this we pre-incubated JG cells with 10 uM hydrogen peroxide (H2O2) for 1 hr. After this, the medium was removed and H2O2 was completely washed out from JG cells followed by treatment with vehicle (cont) or 10 uM leptin. We found that, in cells pre-treated with H2O2, leptin increased renin release by 49.2 ±16 %(P<0.05 vs vehicle). By Western blot, we detected the expression of the leptin receptor in lysates from JG cells. We concluded that under normal conditions leptin inhibits renin release from JG cells. However, after exposure to H2O2, leptin stimulates renin release. Our data suggest the hypothesis that oxidative stress reverses the inhibitory effect of leptin on renin release and supports a pro-hypertensive role for leptin during chronic inflammatory conditions that induces oxidative stress.


2009 ◽  
Vol 137 (11-12) ◽  
pp. 690-696
Author(s):  
Nada Dimkovic ◽  
Sinisa Dimkovic

The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabolic factors as intraglomerular hypertension and glomerular hypertrophy. Although tight blood pressure control is the major preventive mechanism for progressive renal failure, ACE inhibitors and angiotensin receptor blockers have some other renoprotective mechanisms beyond the blood pressure control. That is why these two groups of antihypertensive drugs traditionally have advantages in treating renal patients especially those with proteinuria over 400-1000 mg/day. Even if earlier experimental studies have shown renoprotective effect of calcium channel blockers, later clinical studies did not prove that calcium channel blockers have any advantages in renal protection over ACE inhibitors given as monotherapy or in combination with ACE inhibitors. It was explained by action of calcium channel blockers on afferent but not on efferent glomerular arterioles; a well known mechanism that leads to intraglomerular hypertension. New generations of dihydropiridine calcium channel blockers can dilate even efferent arterioles not causing unfavorable haemodynamic disturbances. This finding was confirmed in clinical studies which showed that renoprotection established by calcium channel blockers was not inferior to that of ACE inhibitors and that calcium channel blockers and ACE inhibitors have additive effect on renoprotection. Newer generation of dihydropiridine calcium channel blockers seem to offer more therapeutic possibilities in renoprotection by their dual action on afferent and efferent glomerular arterioles and, possibly by other effects beyond the blood pressure control.


2014 ◽  
Vol 5 ◽  
Author(s):  
Sheila K. Patel ◽  
Elena Velkoska ◽  
Melanie Freeman ◽  
Bryan Wai ◽  
Terase F. Lancefield ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document